Cardio Diagnostics Holdings - Rasio nilai perusahaan marang pendapatan CDIO

After evaluating the EV/Sales multiple on GURU.Markets, we find that the figure is 65000.00. Cardio Diagnostics (CDIO) is scaling its IT platform through telemedicine partnerships. Patents for the genetic analysis of cardiac pathologies protect its niche from large laboratory networks. Epigenetic tests are being implemented in collaboration with primary care clinics for the effective prevention of vascular diseases.
Cardio Diagnostics Holdings Inc. - rincian analitis lan metrik utama (CDIO)

This multiple determines the total enterprise value, including debt and minus cash, per unit of sales, allowing for an assessment of asset monetization efficiency regardless of financial leverage. The price action of the EV/Sales ratio reflects market expectations for the scaling of the Cardio Diagnostics (CDIO) AI platform, where a high valuation is justified by the network effect of data and high customer switching costs.